Tularemia, unspecified
ICD-10 A32.9 is a billable code used to indicate a diagnosis of tularemia, unspecified.
Tularemia is an infectious disease caused by the bacterium Francisella tularensis, which is primarily transmitted to humans through contact with infected animals, bites from infected insects, or inhalation of contaminated aerosols. The disease can present in various forms, including ulceroglandular, glandular, oculoglandular, or pneumonic, depending on the route of infection. Symptoms may include fever, chills, headache, muscle aches, and swollen lymph nodes, with the potential for severe complications if left untreated. Diagnosis is typically made through clinical evaluation and serological testing, as well as culture of the organism from infected tissues or fluids. Treatment usually involves antibiotics such as streptomycin or doxycycline, with early intervention being crucial for a favorable outcome. The unspecified nature of this code indicates that the specific form of tularemia is not documented, which may complicate treatment and management strategies.
Detailed clinical history, exposure history, and laboratory results.
Patients presenting with fever and lymphadenopathy after potential exposure to wildlife.
Ensure thorough documentation of symptoms and exposure to facilitate accurate coding.
Comprehensive patient history and symptom assessment.
Patients with flu-like symptoms and potential exposure to infected animals.
Documenting travel history and animal contact is crucial for accurate diagnosis.
Used when laboratory confirmation of tularemia is required.
Document the source of the culture and clinical suspicion of tularemia.
Infectious disease specialists may require additional lab tests.
Tularemia is a bacterial infection caused by Francisella tularensis, which can be transmitted through contact with infected animals or insect bites.
Diagnosis is made through clinical evaluation, serological testing, and culture of the organism from infected tissues or fluids.
Treatment typically involves antibiotics such as streptomycin or doxycycline, with early intervention being crucial for recovery.
